News and insights into the #2 pharma/medtech market - China

Greg B. Scott founded ChinaBio® in 2007 to help western life science companies achieve success in China. ChinaBio® is a consulting and advisory firm based in Shanghai that has helped over 100 U.S., European and APAC companies seeking partnerships, acquisitions, novel ... more

ALL CONTRIBUTIONS

Week In Review: Tianjin CanSino Closes $65 Million Round For Vaccine Portfolio
Tianjin CanSino Biologics, a vaccine developer, raised $65 Million in its latest funding round. Currently, CanSino is testing four products in Phase I to III clinical trials, conducted in North America, Africa and China respectively.
Read
Week In Review: Dalian Wanda Plans $10 Billion Chengdu Healthcare Park
Dalian Wanda Group, unveiled plans to invest $10bn in a Chengdu healthcare park. Plans call for the park to include two tier-one general hospitals, eight smaller specialized hospitals and 30 healthcare-related firms.
Read
Week In Review: Zai Lab Partners With GE On China Biologics Manufacturing
This week in China biotech features a partnership with GE Healthcare in biologic drug manufacturing and the South Korea government launching a multi-million dollar fund to encourage biotech startups.
Read
Week In Review: Beijing's Creat Offers $1.3 Billion For Biotest Of Germany
Creat Group, a Beijing investment firm, has bid to acquire German blood plasma products maker Biotest for $1.3 billion (including debt).
Read
Week In Review: Two Major China CROs Move Toward China Public Listings
Wuxi AppTec, China's largest CRO/CMO, has begun the application process for an IPO on a China exchange. ShangPharma will combine all of its CRO/CMO operations under the ChemPartner name and merge the entity, with a public company.
Read
Week In Review: BGI Genomics Plans $250 Million Shenzhen IPO
BGI Genomics, the contract sequencing and diagnostics divisions of China genomics sequencing company BGI, filed to IPO on the Shenzhen Chi-Next exchange with a proposed target of raising $250 million.
Read

STOCKS I FOLLOW

AXN Aoxing Pharmaceutical Company, Inc.
CRPNF China Pioneer Pharma Holdings Ltd.
CYIG CHINA YCT INTL GROUP
HCM Hutchison Chi-Med
ICLR Icon PLC
MCRPF MICROPORT SCIENTIFIC
MDCO The Medicines Company
MR Mindray Medical International Limited
NBY NovaBay Pharmaceuticals, Inc.
SCLN SciClone Pharmaceuticals, Inc.
WX WuXi PharmaTech Inc.
Load More

TWEETS

LATEST ACTIVITY

ChinaBio® Today
Week In Review: Tianjin CanSino Closes $65 Million Round For Vaccine Portfolio $MRK $MRK $PFE $CELG $IONS $BGNE https://t.co/Zn9hdMB0OX less
ChinaBio® Today
Week in Review: Dalian Wanda Plans $10 Billion Chengdu Healthcare Park $AIQ $...

more
ChinaBio® Today
RT ftchina: ChemChina’s purchase of Syngenta garners China regulatory approval https://t.co/YYGWBiXhBc...

All Posts

PERSONAL BLOG

Latest Posts

Work Experience

Education

Publications